期刊
DNA REPAIR
卷 6, 期 9, 页码 1391-1394出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.dnarep.2007.03.019
关键词
glioblastoma multiforme; glioma stem cell; radiosensitivity; cell cycle checkpoints; radiotherapy
资金
- Medical Research Council [G108/589] Funding Source: Medline
- MRC [G108/589] Funding Source: UKRI
- Medical Research Council [G0300662B, G108/589] Funding Source: researchfish
Attempts to improve outcomes for patients with glioblastoma multiforme have focused largely on dose intensification and multimodal therapy and have been met with limited success. An alternative approach involves identifying and targeting the mechanisms responsible for tumour resistance. Recent data suggests that these high grade malignancies harbour a population of glioma stem cells that are both radioresistant and capable of initiating tumour regrowth. Furthermore, the radioresistant phenotype may be the consequence of constitutively upregulated and hyper-responsive cell cycle checkpoint pathways. This article considers whether these findings herald the dawn of a new era of effective, targeted therapy for this refractory tumour. (C) 2007 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据